Viewing Study NCT05368818

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-06-07 @ 1:19 PM
Study NCT ID: NCT05368818
Status: COMPLETED
Last Update Posted: 2022-07-01
First Post: 2022-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data Source
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cosentyx, View
None Secukinumab, View
None Quality of Life, View
None UK View